Biogen (BIIB) A Roadmap...BIIB came out a nice Gartley Pattern on 4/22. First stop should be the $277 area as AB=CD, where I would think there will be some profit taking. Upside targets ($290+) are shown as this evolves into a possible Deep Crab Harmonic Pattern. Biogen needs FDA drug approval, descent earning against healthy market backdrop for this to happen. In higher time-frames you may also have a cup and handle formation. As usual do your own DD S.Longby Steve666Updated 110
#BIIB good risk/rewardNASDAQ:BIIB #BIIB Possible breakout: Risk/Reward ratio 3.47Longby otbglobalinvestments1
BIIB has incoming Golden Cross, rising past support zone?Hi. In this 1D chart I've marked an impending Golden Cross: the point where a MA 56 is very likely to cross a MA 224 upwards. With this I've also plotted out a Resistance zone and a Support zone. The price has just entered the Resistance zone but instead of turning back this time the momentum of the Golden Cross should push it past the Resistance zone. I've also included two example trades. One has its SL placed on the price of the Golden Cross and then given a ratio of two to make a reasonable TP. The other has its SL placed on the top line of the Support zone and given a ratio of 1.75 to make a more conservative long position and keep the TP within a reasonable price. Thank you. Please, if you have any thoughts or comments do leave them below and I would gladly discuss or adjust my interpretations and methods with you. This does not constitute financial advice. Any projected prices, even if explicitly stated, are made with intent to discuss the symbol and potential interpretations. Any trades shown or mentioned are examples and neither recommendations or mandates.Longby Kabeldon1
BIIB: Biogen triangle breakoutBIIB has broken out of triangle triangle formation on strong signals from super guppy and MACD indicators. I expect this breakout to continue on both its solid technical's as well as the strong sentiment in regards to BIIB's potential ceiling. Two crucial stories to watch going forward are the potential appeals court reversal related to their multiple sclerosis drug patent and more importantly, the potential approval of their experimental Alzheimer's drug. I believe there is a good opportunity in the short-term with strong risk/reward. I anticipate some quick upside in the short term (5-10%) and will be happy to take profits. The longer-term picture for Biogen certainly has a ton of upside potential however, there is very significant risk. Biogen has a lot riding on the 2 drugs mentioned above and the ruling made on them has the potential to make or break the company's future. I believe once a decision is passed down we will either see price rapidly surge to $400+ or rapidly fall to $175-$220 depending on the outcome. by LivermoreGrahamDisciple114
It's a big "IF"IF it breaks out of the red zone in its monthly chart, then $800 is possible.by KhanhC.Hoang660
$BIIB Biogen Big Move Pre-Market Potential entry above the 200ma @ $280 Target price $300Longby RedHotStocks0
BIIB longRanging -> breakout -> retest -> go? We will see. I cant predict the future. Tail or fade, idcLongby freddiegbruhUpdated 0
mini downtrendits a great longterm play if you got in a while ago! id wait for the top trendline to break to get long but this is a good reward if you use a tight stop on shares. but be careful if support breaks theres no floor on this one. it could be a nasty dump. goodluck :) Longby Vibranium_Capital18
Biogen INC, pharmaceutical stock that is going to runBiogen INC 22 June, we were monitoring this stock. Its been 1 month, we are still waiting for a good entryLongby ForexTradingSchoolUpdated 5
great chart request!we are looking at 100 dollars of upside after this final top line breaks! dang thanks for the request.. on my watchlist now :) leave a like if you enjoyed my idea <3Longby Vibranium_Capital21
BIIB on watchMassive move today on positive drug new. May to be tough to get an entry on this as I don't want to chase. I will be looking for price to consolidate at the highs with good volume. Not interested if price has wild swings. Longby WadeYendall4
200 will be a good entry for BIIBRead latest news here Now, in the world of healthcare stocks, there are aplenty that one can invest in. My concern is its revenue growth is choppy and its involvement in Covoravirus - is it a long term play or seize the market opportunity thing ?? So, on fundamentals and peers to peers comparison, you may have to dig deeper if you want to invest in this company. And no, just because WB is an investor does not make this an automatic buy for me, maybe for you. Please note that I am getting more enquiries on stocks analysis, views and market outlook and I apologised that I can't answer all of them and as fast as I would like to. Longby dchua1969Updated 2